The 91 does not typically rely on exempt determinations made by other institutions, nor does it usually allow other institutions to formally rely on 91’s exempt determinations. Reliance for exempt research may be permitted only in very limited circumstances, as determined by HSD leadership.
If your research is exempt:
Resources:
In Zipline, selecting “Mܱپ-ٱ/DZǰپ” means that one or more non-91 institutions are actively involved in conducting the research with human subjects.
This is not about where 91 researchers travel or recruit participants. It only applies when non-91 investigators or study teams are performing research activities such as obtaining consent, conducting study procedures, or collecting identifiable data.
Examples:
For more help deciding, review our Engagement Guidance or contact hsdrely@uw.edu.
91 IRB review of multi-institutional research is not guaranteed unless HSD has been consulted in advance, or the collaboration is covered by an established cooperative agreement (for example, with Fred Hutch or Seattle Children’s).
Before selecting this review path, consult HSD’s Reliance Team at hsdrely@uw.edu to determine whether 91 IRB review is appropriate for a collaborating institution.
For more information:
91 IRB review of a multi-site or collaborative study happens in 2 phases. Phase 1 must be completed and approved before Phase 2 can begin.
For more information:
All applications must be submitted via Zipline, 91’s eIRB system. Zipline is a document management system where you upload your application form and other study documents and fill out a series of electronic SmartForms.
The order of the application steps is flexible. You may find it better to create the study record in Zipline and then complete the Word-based IRB application form, especially if you plan to be a PI proxy for a study.
91 study team members who need access to the Zipline application must complete a one-time self-registration process in Zipline before they can be added to the application. Each person must be added to the application before they are able to access it.
Individuals from non-91 institutions cannot access Zipline.
A 91 NetID is required to register. For more information:
All applications must include an IRB Protocol Form. Use the most recent version available on the HSD website or in Zipline and upload the form in Microsoft Word format. .
Two versions of the form are available:
Tips for multi-site and collaborative studies
For more guidance, go to Preparing and Submitting the sIRB Application.
We recommend preparing all other required study documents before creating your application in Zipline. Whenever possible, upload documents in Microsoft Word format.
Required Supplements
Your application must include one or both of the following supplements, as applicable:
Planning Consent Materials for Multi-site and Collaborative Studies
For multi-institutional research, consent materials are typically developed using a study-wide template created by the overall study team, which sites then adapt to local requirements. HSD does not create this template. You may need to coordinate with investigators at other institutions to develop it.
When submitting the STUDY application in Zipline, you will need:
For more information, go to Designing the Consent Process: Considerations for Multi-institutional Research.
Other Required Documents
You may also need to prepare other required study documents and 91 site specific documents, as applicable. A full list is included in the table under Step 4.
Keep documents specific to non-91 sites for later. These materials will be submitted as part of the SITE application process.
Once your documents are ready, login to Zipline to create a new study record, complete the SmartForm application, and upload the study documents.
To create a new study record, select Create New Study from the menu:





| SmartForm Page & Attachments | Tips & Guidance |
|---|---|
| Basic Information SmartForm Page Attachments:
|
The Basic Information page should indicate that:
The IRB Protocol must be uploaded in format. No other documents should be uploaded in this question. An attachment is required to save the application. |
| Study Funding Sources SmartForm Page Attachments:
|
For funding administered through 91:
|
| Local Study Team Members SmartForm Page No attachments |
Can’t find someone on the list? Make sure they are registered in Zipline.
Add everyone who needs access to the application, including anyone who should be designated as a PI proxy. People must be listed on this page in order for the PI to designate them as a proxy. Students/medical residents: Do not list your faculty advisor. Adding your faculty advisor on this page prevents them from completing faculty advisor review of your application. |
| Study Scope SmartForm Page No attachments |
Questions should be answered as they apply to the overall study, not just the 91 site. If you are unsure how to respond to a question, use the help text for more information. |
| Local Research Locations No attachments |
If your research location is not listed, select Other.
If your research consists solely of obtaining records, specimens, or other information without interacting with participants, select No direct interaction with participants. |
| Drugs SmartForm Page (if applicable) Attachments:
|
Identify all drugs to be used on human subjects as part of this study, including all investigational new drugs (INDs). An IND number is assigned by the FDA to a drug that the FDA allows to be transported across state lines for use in clinical studies prior to marketing approval.For each IND number, attach one of the following:
|
| Devices SmartForm Page (if applicable) Attachments:
|
Identify all devices to be evaluated for safety and effectiveness or used as an HUD on human subjects. Include all information the IRB needs to identify and evaluate any device with exemptions or claimed exemptions. Also, attach information from the study sponsor or the FDA verifying the exemption status of each exempt device. |
| Study Related Documents Page Attachments:
|
Only attach documents that apply to the overall study and are not specific to the 91 site, such as generic study consent templates that will be adapted for each site. Documents specific to the 91 site should be attached on the Local Site Documents Page. |
| Local Site Documents Page Attachments:
|
Consent forms:
Recruitment materials:
Other documents:
|
The Manage Ancillary Review activity is used to obtain and document faculty advisor review when a student or medical resident is the principal investigator (PI) for the IRB application. Do not add the faculty advisor to the study team on the Zipline application before the faculty advisor has submitted the faculty advisor review. The system will not allow a member of the study team to submit an ancillary review for the study.
The faculty advisor review may occur concurrently with HSD or IRB review of an application. However, final IRB approval will not be issued until the required faculty advisor review is completed.
Your faculty advisor will receive an email notification when the application is submitted to HSD. For more information:

Checking the application for errors and omissions helps you to include all the relevant information, which is essential for receiving a timely review of your study. Automatic system error checking identifies any omitted answers to questions that are required for every application. A red asterisk (*) indicates required questions.
HSD also recommends looking over the forms to see what you may have missed, especially:
The Submit activity must be completed once the application is ready to go to HSD. This activity:

An HSD staff member will be assigned to your application as the IRB coordinator. The PI, any PI proxies, and the primary contact will receive email notifications:
You can check the application status in the study workspace in Zipline at any time.

Once the STUDY is approved, HSD will work with you to begin adding relying SITES and site specific information, including documents such as consent materials.
For more information: